Many variations of the polymerase chain reaction (PCR) have recently evolved, enhancing this powerful tool for use in cloning, nucleic acid sequencing and diagnostic testing. Construction of a large number of PCR reactions typical for diagnostic applications (HLA typing, genetic screening, microbial identification) requires time-consuming and repetitive pipeting. Even a master mix made in the laboratory or supplied with kits requires assembly of completed PCR reactions. We have developed a technique for encapsulating all of the components of a PCR reaction, including polymerase as well as gel loading buffer and dye, in an agarose matrix that can be easily shipped in pre-aliquoted tubes and stored for months at -20_C. To complete the PCR reaction the researcher need only add DNA template to the matrix and commence thermocycling. After thermocycling the reaction can be loaded directly onto an agarose gel for analysis. This technique enables one to make identical sets of reactions at one time which can be distributed into 96-well plates, strip tubes or single tubes in a form suitable for storage, shipping and room temperature assembly of reactions.
To determine the appropriate agarose with which to encapsulate the PCR reactants, various agarose types and concentrations were tested to ascertain whether there was any inhibitory effect on PCR reaction yield. A comparison of conventional PCR reactions with those containing 0.1-0.5% agarose (Fisher Biotech agarose, cat.#BP1356-100, Fisher Biotech, Fairlawn, NJ; NuSieve 3:1, cat.#50092, FMC, Rockland, ME; low-melting point agarose, cat.#A-9414, Sigma Chemical Co., St Louis, MO and Trevigel 500 cat.#9804-25-P, Trevigen, Gaithersburg, MD) revealed that agarose has no inhibitory effect on the yield of PCR products even at low template concentration (100 copies in a 50 µl reaction volume). Although the total yield in each reaction was not quantitated, visual inspection indicated no difference in product yield, spurious band formation or primer-dimer formation between conventional PCR and agarose-containing PCR. For subsequent testing purposes, Trevigel 500 was selected because: (i) it has the highest reported melting temperature (good hot start quality), (ii) it is the only agarose reported to be DNAse and RNAse free and (iii) it has high gel strength (important in shipping).
An additional consideration when formulating an appropriate agarose matrix is to determine the concentration which yields good mechanical properties without interfering with post-reaction pipeting due to increased viscosity. The limits which appear to fit this criteria is an encapsulation matrix of 0.5% which yields a post-reaction agarose concentration of <0.07%.
To demonstrate this technique, all the reagents available in the Perkin-Elmer Gene Amplimer kit (Perkin-Elmer, Foster City, CA) for the detection of HIV-1 gag gene, except for DNA template, were encapsulated in an agarose matrix. Table 1 lists the concentration of the components of the encapsulations and the final concentrations of the components for a 25 µl reaction volume. Assembly of 10 encapsulated reagents was performed in the following manner. Appropriate amounts of dry reaction components 1-7 (including a set of primers for HIV-1 gag gene) were resuspended in 25 µl of a 0.5% agarose/50% glycerol solution (58_C), after which 5.0 U Taq polymerase was added to the mixture. An aliquot of 2.5 µl of this molten encapsulation solution was then added to each of 10 × 0.2 ml thin-walled PCR tubes, allowed to gel and placed in a -20_C freezer for 2 weeks. Three encapsulated reactions were tested against freshly prepared PCR reactions incorporating the reactant without agarose matrix. A solution containing 5000, 1000 or 500 copies of HIV-1 template was added to the encapsulated reactions and freshly made controls. The amplification was performed according to the Gene Amplimer protocol by cycling the samples through a 1 min denaturing step (94_C), followed by 30 cycles of alternating 60_C for 60 s and 94_C for 60 s. The reactions were cooled to room temperature and 10 µl was loaded onto a 4.0% NuSieve (FMC BioProducts) agarose gel for analysis. According to the protocol, a 115 bp product is generated from the amplification of the gag gene from HIV-1. As can be seen in Figure 1 , the control PCR reactions and the stored encapsulated reactions appear identical, even at low copy number (∼500). Encapsulated reactions have been stored for up to 3 months at -20_C with no decrease in product yield. The fact that the encapsulation matrix is 50% glycerol should increase the stability of the thermostable polymerase. We have utilized this system for a variety of amplifications including human DNA tissue for HLA typing and microbial 16S DNA amplification. In each case we have been successful in producing a PCR product whose yield is equal or superior to that obtained by conventional PCR. Encapsulated reactions have been shipped on ice and at ambient temperature to other laboratories where researchers have used them after several months without noticing any decrease in performance. Preliminary data indicate that agarose encapsulated reactions can be stored at room temperature for up to 2 weeks without decrease in product yield.
Sequestration of the reactants in the agarose matrix may prevent interaction with a DNA template until an elevated temperature is reached (∼90_C) and thus may be useful in the detection of a low-copy number template in the presence of high background (1). In addition to this 'hot-start' effect, encapsulation provides room temperature assembly of reactions and reduced cross-contamination (fewer pipeting steps). We are presently attempting to use this system to simplify assembly of reactions for high throughput cycle sequencing, random primer labeling and RT-PCR.
